Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2022-10-20 Regulatory Filings
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Navamedic ASA launches ForlaxGO® - an innovative on-the-go product for the treatment of constipation
Regulatory Filings Classification · 100% confidence The document is a short press release dated October 20, 2022, announcing the launch of a new product, ForlaxGO®, in Nordic pharmacies. It details the product, the agreement with Ipsen, and includes quotes from the CEO regarding growth targets. This type of announcement, which is a general corporate update about a business event (product launch) rather than a mandatory financial filing (like 10-K, IR, ER), best fits the category for general regulatory announcements or miscellaneous corporate news. Since it is not a specific financial report, management change, or dividend notice, and it is a direct announcement, it falls under the general 'Regulatory Filings' (RNS) category, which serves as a broad category for non-standard corporate disclosures, or potentially a general 'Report Publication Announcement' (RPA) if it were announcing a report, but here it announces a product launch. Given the nature of the announcement (product launch/business update), RNS is the most appropriate fallback for non-standard corporate news that isn't explicitly defined elsewhere.
2022-10-20 English
Navamedic ASA: Resultater for andre kvartal og første halvår 2022
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for Navamedic ASA covering the second quarter and the first half of 2022. It includes detailed financial statements (income statement, balance sheet, cash flow), management's discussion and analysis (CEO comments, operational review), and notes to the interim financial statements. It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2022
2022-08-12 English
Navamedic ASA: Resultater for andre kvartal og første halvår 2022
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for Navamedic ASA covering the second quarter (Q2) and first half (H1) of 2022. It includes detailed financial statements (Profit and Loss, Balance Sheet, Cash Flow), management commentary on business performance, and operational highlights. It is not a short announcement or a certification, but a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q2 2022
2022-08-12 English
Navamedic ASA: Resultater for andre kvartal og første halvår 2022
Earnings Release Classification · 100% confidence The document is titled "Navamedic ASA: Resultater for andre kvartal og første halvår 2022" (Results for the second quarter and first half of 2022). It contains key financial metrics (revenue, gross margin, EBITDA, EBIT) for Q2 2022 and H1 2022, along with commentary from the CEO. This content strongly indicates a periodic financial results announcement. Since it provides comprehensive results for a period shorter than a year (Q2 and H1), it fits the definition of an Interim/Quarterly Report (IR). Although it mentions an upcoming presentation, the core content is the financial results themselves, not just the announcement of the report's release (which would be RPA/RNS). It is too detailed for a simple Earnings Release (ER) which usually contains only highlights. H1 2022
2022-08-12 Norwegian
Navamedic ASA: Q2 and first half 2022 financial results
Earnings Release Classification · 100% confidence The document explicitly announces the 'Q2 and first half 2022 financial results' for Navamedic ASA. It provides key financial highlights (revenues, gross margin, EBITDA, EBIT) and commentary from the CEO. This content structure—a press release summarizing period results—is characteristic of an Earnings Release (ER). Although it mentions an attached presentation and a webcast, the primary content provided is the summary of the results, not just the announcement of the report's availability. Therefore, ER is the most appropriate classification over RPA or RNS. Q2 2022
2022-08-12 English
Navamedic ASA: Invitation to 2022 second quarter presentation
Earnings Release Classification · 95% confidence The document is titled "Navamedic ASA: Invitation to 2022 second quarter presentation" and explicitly states that the company "will be presenting its second quarter 2022 results on Friday, August 12." It provides details about the physical presentation time and a link to a live webcast. This is a short announcement whose primary purpose is to inform stakeholders about an upcoming event where financial results (for Q2 2022) will be discussed, rather than being the full results document itself (which would likely be an ER or IR). Since it is announcing a presentation event, it most closely aligns with the purpose of an Earnings Release (ER) announcement, although it is specifically an invitation to the presentation event itself. Given the options, an invitation to an earnings presentation is best categorized as an Earnings Release (ER) announcement, as it precedes or accompanies the release of the period's results. Q2 2022
2022-08-09 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.